Musaffa Logo

AIDX Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, 20/20 Biolabs Inc is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

20/20 Biolabs Inc

20/20 Biolabs Inc. Stock Analysis AIDX

United States Health Care Nano Cap Report:
20/20 Biolabs, Inc. engages in development and commercialization of proteomics product line. The company is headquartered in Rockville, Maryland and currently employs 4 full-time employees. The firm offers OneTest, a simple blood test for multiple cancers, harnesses the power of Artificial Intelligence (AI) to help identify the disease at an earlier, more treatable stage. Onetest helps detect Lung, Liver, Pancreatic, Prostate, Kidney, Ovarian and many other cancers with a single blood test.
Read More

20/20 Biolabs Inc (AIDX) Chart

Key Statistics of 20/20 Biolabs Inc (AIDX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.52$0.54

Today's Open

$0.52

Volume

144.01K

P/E Ratio (TTM)

-

52 Week Range

$0.49$50.00

Market Cap

7.08M

Avg. Volume

341.05K

Dividend Yield

-

Financial Metrics & Statements of 20/20 Biolabs Inc (AIDX)

Super Investors Invested in 20/20 Biolabs Inc (AIDX)

FAQ's for 20/20 Biolabs Inc (AIDX)

  • As of July 2026, 20/20 Biolabs Inc AIDX is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes 20/20 Biolabs Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in 20/20 Biolabs Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of 20/20 Biolabs Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of 20/20 Biolabs Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of 20/20 Biolabs Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.